Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,814.53
(
-0.15%
)
US TECH 100
24,408.02
(
0.00%
)
Dow Jones
47,898.07
(
-0.60%
)
Brent Oil
94.78
(
0.34%
)
Bitcoin
73,019.46
(
1.72%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122860
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 242384

Monday, 10/03/2022 10:25:06 AM

Monday, October 03, 2022 10:25:06 AM

Post# of 257375
AZN acquires LOGC for $2.07/sh cash—a 667% premium to Friday’s close (not a typo), but a 44% discount to LOGC’s 12-month high and a 79% discount to LOGC’s 2018 IPO price (#msg-144332035):

https://finance.yahoo.com/news/alexion-astrazeneca-rare-disease-acquire-111500187.html

The 667% premium is the highest I’ve ever seen for a biotech buyout. The nominal deal value is $70M.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today